Bowel preparation in patients undergoing diagnostic colonoscopy. Encounter for other specified special examinations
Conditions
Interventions
Intervention 1: Intervention group: In the polyethylene glycol (PEG) group, patients receive Pedrolax starting 24 to 48 hours before colonoscopy. One 70-g sachet of Pedrolax (manufactured by Sepidaj P
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Years to 18 Years
Inclusion criteria
Inclusion criteria: Patients with gastrointestinal symptoms suggestive of digestive disorders, including chronic diarrhea, abdominal pain, rectal bleeding, or unexplained iron deficiency anemia, requiring colonoscopy. Informed consent to participate in the study. The patient and their parents or guardians had to be able to cooperate with the bowel preparation process and colonoscopy procedure.
Exclusion criteria
Exclusion criteria: Presence of severe medical conditions or chronic diseases that could compromise the safety of colonoscopy (such as severe cardiac or pulmonary disorders).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Drug tolerance status. Timepoint: After the intervention. Method of measurement: Patient history.;Stool form. Timepoint: After the intervention. Method of measurement: Patient history.;Stool volume. Timepoint: After the intervention. Method of measurement: Patient history.;Requires suctioning. Timepoint: After the intervention. Method of measurement: Patient history. | — |
Secondary
| Measure | Time frame |
|---|---|
| Mucosal condition. Timepoint: After the intervention. Method of measurement: Patient history.;Colonoscopy appointment. Timepoint: After the intervention. Method of measurement: Patient history.;Need for repeat colonoscopy. Timepoint: After the intervention. Method of measurement: Patient history. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Amir Hossein Hosseini
Shahid Beheshti University of Medical Sciences
Outcome results
None listed